Novavax: Late-stage trial of potential COVID-19 vaccine begins in UK

Click here to get this post in PDF

Two COVID-19 vaccines being tested in the UK have moved on to the third phase of trials, marking a significant step forward in the development process.

One of the vaccines, Novavax, will be tested on around 10,000 participants aged between 18 and 84 years over the next four to six weeks.

To read more, click here:

SUBSCRIBE to our YouTube channel for more videos:

Follow us on Twitter:

Like us on Facebook:

Follow us on Instagram:

For more content go to and download our apps:



Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí